Latest News
Aardvark Therapeutics, Inc.
- Why Is Aardvark Therapeutics Stock Trading Lower Today? - Aardvark Therapeutics (NASDAQ:AARD)
- FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns
- Form 8K Aardvark Therapeutics Inc For: 23 October By Investing.com
- Aardvark Therapeutics, Inc. Estimates – BOATS:AARD
- Aardvark reports exploratory data from terminated PWS trial By Investing.com
- Aardvark Therapeutics Announces FDA Has Lifted The Clinical Hold On Ard-101 For The Treatment Of Prader-Willi Syndrome And Will Host Webcast To Review The Available Exploratory Phase 3 Hero/Ole Data
- Form 8K Aardvark Therapeutics Inc For: 22 October By Investing.com
- Form 8K Aardvark Therapeutics Inc For: 22 October By Investing.com
- Form 4 Aardvark Therapeutics Inc For: 9 October By Investing.com
- Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors
- AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
Headlines from the last 30 days, linking to the original publishers. See all market news →